首页 | 本学科首页   官方微博 | 高级检索  
     

益气通络方对缺血性肾病早期大鼠肾组织及ICAM-1表达的影响
引用本文:李伟,刘兰英,李娇艳,李根茂,葛东宇. 益气通络方对缺血性肾病早期大鼠肾组织及ICAM-1表达的影响[J]. 世界中西医结合杂志, 2013, 0(10): 1000-1002,1006
作者姓名:李伟  刘兰英  李娇艳  李根茂  葛东宇
作者单位:[1]北京中医药大学第三附属医院,北京100029 [2]北京中医药大学,北京100029
基金项目:北京中医药大学自主课题资助项目(No.2011JYBZZJS-029)
摘    要:目的观察益气通络方对缺血性肾病早期大鼠的肾组织及其血管细胞间黏附分子-1(ICAM-l)表达的影响,探讨其防治缺血性肾病早期病变的机制。方法采用双侧肾动脉不全结扎术导致的双侧肾动脉狭窄建立缺血性肾病动物模型。SD雄性大鼠随机分为假手术组、模型组、预防组、药物组,于造模后14 d取材。采用HE染色及Masson染色观察肾组织病理学变化;应用免疫组化检测ICAM-1的表达。结果 HE染色及Masson染色结果显示模型组、预防组、药物组与假手术组比较都有不同程度的炎症及纤维化病灶,预防组与模型组比较,炎症及纤维化程度减轻;预防组、模型组与假手术组比较,ICAM-1表达增加;预防组与模型组比较,ICAM-1表达显著减少。结论益气通络方可能通过减少ICAM-1的表达,从而防治缺血性肾病的早期病变。

关 键 词:益气通络方  缺血性肾病  ICAM-1

Impacts of Yiqi Tongluo Formula on Renal Tissue and ICAM -1 Expres- sion in the Rats of Early Ischemic Nephropathy
LI Wei;LIU Lan-ying;LI Jiao-yan;LI Gen-mao;GE Dong-yu. Impacts of Yiqi Tongluo Formula on Renal Tissue and ICAM -1 Expres- sion in the Rats of Early Ischemic Nephropathy[J]. World Journal Of Integrated Traditional and Wesrern Medicine, 2013, 0(10): 1000-1002,1006
Authors:LI Wei  LIU Lan-ying  LI Jiao-yan  LI Gen-mao  GE Dong-yu
Affiliation:LI Wei1 , LIU Lan - ying1 , LI Jiao -yanI , LI Gen - mao2 , GE Dong - yu2 ( 1. The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine, Beijing 100029 ; 2. Beijing University of Traditional Chinese Medicine, Beijing 100029)
Abstract:Objective To observe the impacts of Yiqi Tongluo Formula on renal tissue and ICAM - 1 expression in the rats of early ischemic nephropathy and explore its mechanism on prevention and treatment of early ischemic nephropathy. Methods The incomplete ligation of bilateral renal arteries was adopted to induce bilateral renal arterial stenosis and establish the animal model of ischemic nephropathy. SD male rats were randomized into a sham - operation group, a model group, a prevention group and a medication group. The material was collected in 14 days after modeling. HE staining and Masson staining were used to observe the pathological changes in renal tissues. HTC was applied to detect the expression of ICAM - 1. Results In the observation with HE staining and Masson staining, compared with the sham -operation group, the inflam- matory disorders and fibrosis foci were displayed to different extents in the model group, the prevention group and the medication group. Compared with the model group, the degree of inflammatory disorders and fibrosis were alleviated in the prevention group. Compared with the sham - operation group, ICAM - 1 expression was increased in the prevention group and the model group. Compared with the model group, ICAM - 1 expression was reduced significantly in the prevention group. Conclusion Yiqi Tongluo Formula prevents and treats early ischemic nephropathy probably via reducing the expression of ICAM - 1.
Keywords:Yiqi Tongluo Formula  Ischemic Nephropathy  ICAM - 1
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号